THE ROLE OF BETA-BLOCKERS IN VETIANGINAL THERAPY IN THE CORRECTION OF VIOLATIONS OF THE AMINO ACID SPECTRUM IN PATIENTS WITH UNSTABLE ANGINA WITH CONCOMITANT DIABETES MELLITUS
Keywords:non-stable angina, diabetes mellitus, amino acid, bisoprolol, nebivolol
The purpose of the study: to study the effect of bisoprolol and nebivolol on the spectrum of essential blood plasma AK in patients with concomitant diabetes mellitus (DM) type 2 in order to optimize drug treatment of this pathology in the future.
Material and methods. The study involved 70 patients with NA with concomitant DM type 2, which was divided into two groups: group I (37 patients) as part of basic antianginal therapy received bisoprolol, group II (33 patients) received nebivolol. The control group (CG) consisted of 18 healthy individuals. All patients were tested for irreplaceable blood plasma AA by ion exchange liquid chromatography on an automatic analyzer AK T-339 produced by «Microtechna» (Czech Republic, Prague) at the Institute of Biochemistry named after OV Palladin NAMS of Ukraine. The following essential AAs were identified: arginine, valine, histidine, isoleucine, leucine, lysine, methionine, threonine, phenylalanine. Examination of patients was performed at the beginning of treatment and after 20 days. Results. It was determined that in patients with NA with concomitant DM type 2 under the influence of antianginal therapy in both groups significantly decreased the total amount of irreplaceable AA compared with control group, indicating an increase in intracellular metabolism as a compensatory response in coronary circulation. It should be noted that in patients of group II, in contrast to patients of group I, under the influence of treatment the level of histidine remained normal. The level of threonine significantly decreased compared to CG and the rate of patients in group I, the level of valine significantly increased compared to pre-treatment, the level of isoleucine significantly decreased compared with CG and with the rate of patients of group I. Importantly, ammonia levels returned to normal under the influence of basic therapy, which included nebivolol.
Conclusion. The dynamics of changes in the levels of individual irreplaceable AA blood plasma, due to the mechanisms of their metabolic transformations in patients with NA with concomitant DM type 2 indicates greater effectiveness of nebivolol and the feasibility of its prescription іn complex of a basic antianginal therapy.
Sahanda IV. Phytotherapy 2018; 1: 56-58. https://doi.org/10.30525/978-9934-588-44-0/25.
Altunina NV. Clin Endocrinol Endocrine Surg 2015;3(51): 30-35. https://doi.org/10.24026/1818-1384.3(51).2015.75064.
Ostroumova OD, Goloborodova IV, Fomina VM Kardiovaskuljarnaja terapija i profilaktika 2018;17(4): 81-93. https://doi.org/10.15829/1728-8800-2018-4-81-94.
Skala LV, Myshanich GI, Skala OV, et al. Int J Endocrinol 2018; 14(3). http://doi.org/10.22141/2224-07126.96.36.1998.136418.
Sinkeev MS, Skvortsov YI, Bogdanova TM, Skvor tsov K.Yu. Int J Applied Fundamental Res 2014; 11(3): 480-484, available at: https://www.applied-research.ru/ru/article/view?id=616.
Belikova YO. Ukr Sci Med Youth J 2017; 2(103): 10-14.
Bogdan TV, Lyzogub VG. Metabolism of amino acids in myocardial ischemia, Kiev, 2016: 207 p.
Huang Y, Zhou M, Sun H, et al. Cardiovasc Res 2011;90: 220-223. https://doi.org/10.1093/cvr/cvr070.
Abduvaliev AA, Zohidov ZM, Nishantaev MK, et al. Uspekhi Sovrem Nat Sci 2013; 9: 11, available at: http://www.natural-sciences.ru/ru/article/view?id=32752.
Dobrovolska RA, Goshovska YuV, Szymanska TV, Sagach VF. Visn He Honey Un-tu 2014; 18(2): 372–375.
Cheonq SH, Moon SH, Lee SJ, et al. Adv Exp Med Biol 2013; 776: 167-177. https://doi.org/10.1007/978-1-4614-6093-0_17.12. Montalescot Gilles. Eur Heart J 2 013; 3 4(38): 2 949-3003. https://doi.org/10.1093/eurheartj/eht296.
Moshkovska YO. Medicines of Ukraine 2015; 190(4): 42-46.
Zavalska TV. Reports of the NAS of Ukraine 2015; 5: 173-177.
Lyzogub VG, TV Zavalska, VV Bogdan, DM Zhornichenko. Reports of the NAS of Ukraine 2015; 6: 167-174.
Severin ES. Biochemistry, Moskva, 2003: 779 p.
Gubergrits NB, Golubova OA, Lukashevich GM. ModernGastroenterol 2012; 64: 114-121.
Lyzogub VG, Zavalska TV, Savchenko OV, Tyravska YuV. Lik Right Doctors Case 2013;5: 22-27.
Witham WG, Yester KA, McGaffin KR. Metabolism 2012. https://doi.org/10.1016/j.metabol.2012.07.02.
Shevchenko VP. Clinical Nutrition, Moskva, 2009: 256 p.